GTC Biotherapeutics (fka GTCB)

[stockdak]

> "with some style" part could be discounted as noblesse
oblige, but the near-browbeating about excluding
hypothetical upfronts from FoB suitors now at the table
seemed very pointed.

I caught that too, as first Dr. Cox said the cash burn excluded any other possible deal payments then the CFO said the same thing. Perhaps they are counting some FoB chickens. At least this time they did not include an amount in their estimates before the deal was signed. That's progresss.